Advantage

GMP produces common & rare cannabinoids

These cannabinoids can be used as Active Pharmaceutical Ingredients (API’s).

View Products
1

INNOVATION

Semi-synthetic production of Δ8 & Δ9 THC, CBD, and other rare cannabinoids.
2

LOW COSTS

Semi-synthetic production of Δ8 & Δ9 THC, CBD, and other rare cannabinoids.
3

SPEED-TO-SALE

Our speed from crude to bulk, or crude to finished product is industry leading

Building Intrinsic Value

GMP provides more value to its customers than any other LP

Our ability to super produce pharma-grade API’s allows us to provide the following:

  • Lower purchasing costs for bulk API’s and finished products
  • Higher purity of cannabinoids (pharma-grade)
  • Greater bio-availability due to nano-suspended production
  • Rare cannabinoids that open vast medicinal R&D possibilities

Production Capabilities

State-of-the-art facility

Our Toronto based state-of-the-art 100,000 sq. ft. facility can produce enough semi-synthetic cannabinoids to concurrently satisfy the following production needs:

Learn More About GMP
1
Bulk API Production
2
Domestic Medical Production
3
Contract Manufacturing for 3rd Parties
4
Tissue Culture of unique cultivars

Product Portfolio

Patented Intellectual Property

Our R&D lab, led by our experienced product development team has perfected several different proprietary nano-suspended formulas that will be first-to-market in the Cannabis landscape. From fine-mist sublingual sprays to nebulizer formulas to IV drips, our team is ensuring ground-breaking formulas and perfect dosing methods for an array of medicinal relief.

Learn More